Lipase
LIP
Description
"Lipase" test measures the level of lipase, an enzyme produced by the pancreas to help digest fats. It’s commonly used to diagnose acute or chronic pancreatitis and evaluate other pancreatic or gallbladder issues. A blood sample is analyzed, and high levels may indicate inflammation or pancreatic damage. Doctors often order this test when symptoms like abdominal pain, nausea, or vomiting appear. Results guide diagnosis, monitor treatment response, and help maintain long-term pancreatic health.
Category
Enzymes
Procedure
Invasive
Sample Type
Blood – Serum
Units
Units Per Liter
Procedure Category
Blood Draw
Test Group
Pancreas Group, Enzyme Group
Test Group Description
Enzyme Group: Evaluates enzyme levels and activity, offering insights into enzymatic function and related health conditions. Pancreas Group: This group encompasses tests related to pancreatic function and health, offering insights into various pancreatic markers and their implications for overall health and wellness.
Optimal Range
For All Individuals:
Conventional Unit: 13.00–60.00 U/L
SI Unit: 13.00–60.00 U/L
Normal Range
For All Individuals:
Conventional Unit: 10.00–140.00 U/L (Up to 60 years) | 24.00–151.00 U/L (60+ years)
SI Unit: 10.00–140.00 U/L (Up to 60 years) | 24.00–151.00 U/L (60+ years)
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Acute pancreatitis (Inflammation of the pancreas)
Biliary tract obstruction (Blockage in the bile ducts)
Crohn's disease (Inflammatory bowel disease affecting the digestive tract)
Gastrointestinal perforation (Hole or tear in the digestive tract)
Pancreatic cancer
Pancreatic duct obstructi...
Key Reasons For Testing
Pancreatitis Diagnosis: Elevated lipase levels help diagnose and monitor pancreatitis.
Abdominal Pain Evaluation: Differentiates between pancreatic and non-pancreatic causes of abdominal pain.
Monitoring Pancreatic Function: Tracks chronic pancreatitis or pancreatic insufficiency.
Evaluation of Digestive Disorders: Assesses impaired fat digestion in malabsorption syndromes.
Monitoring Treatment Response: Measures treatment efficacy for pancreatic disorders.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for pancreatitis and pancreatic cancer: implication of concepts. Gastroenterology. 2015;149(6):1340-1344.
[2] Forsmark CE. The role of serum enzymes and other tests in the diagnosis of acute pancreatitis. Gastrointest Endosc Clin N Am. 1995;5(4):743-757.
[3] Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002;97(6):1309-1318.
[4] Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-2400.
[5] Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400-1415.
[6] Clavien PA, Robert J, Meyer P, et al. Acute pancreatitis and elevated lipase or amylase in ICU patients. Intensive Care Med. 1990;16(4):288-292.
[7] Gumaste VV, Roditis N, Mehta D, Dave PB. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol. 1993;88(12):2051-2055.
[8] Munoz-Bongrand N, Gayet B, Fagniez PL. Role of serum lipase and amylase in nonpancreatic abdominal pain. Am J Gastroenterol. 2001;96(11):3138-3141.
[9] Chang ST, Goudie A, Bogachus L, et al. Elevated serum lipase in emergency department patients with abdominal pain: diagnostic accuracy for acute pancreatitis. Acad Emerg Med. 2013;20(7):703-709.
[10] Smith RC, Southwell-Keely J, Chesher D. Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? ANZ J Surg. 2005;75(6):399-404.
[11] Steinberg WM, Goldstein SS, Davis ND, Shamma'a J, Anderson K. Diagnostic assays in acute pancreatitis: a study of sensitivity and specificity. Ann Intern Med. 1985;102(5):576-580.
[12] Lankisch PG, Weber-Dany B, Maisonneuve P, Lowenfels AB. High serum lipase/amylase ratio discriminates alcoholic from nonalcoholic acute pancreatitis. Pancreas. 2013;42(3):513-517.
[13] Closa D, Sabater L, Fernandez-Cruz L. Serum markers in the management of acute pancreatitis. Ann Ital Chir. 2005;76(6):529-537.
[14] Kupfer Y, Tessler S, Suh SJ, et al. Serum lipase and amylase as predictors of pancreatitis in ICU patients. J Intensive Care Med. 2005;20(1):34-38.
[15] Berger Z, Schlaghecke R, Veit R, Junginger T. Serum lipase determination in acute pancreatitis: diagnostic accuracy in comparison to pancreatic isoamylase. Ann Chir Gynaecol. 1992;81(2):123-126.